Profil
Lei Lin is currently a Director at Jiangsu Subo Biomedical Holding Co. Ltd. Prior to this, she was a Director at Shanghai Rightongene Biotechnology Co., Ltd. from 2019 to 2022 and a Member-Supervisory Board at iRay Technology Co., Ltd. from 2017 to 2023.
Postes actifs de Lei Lin
| Sociétés | Poste | Début |
|---|---|---|
Jiangsu Subo Biomedical Holding Co. Ltd.
Jiangsu Subo Biomedical Holding Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides forensic and third-party medical testing services | Directeur/Membre du Conseil | - |
Anciens postes connus de Lei Lin
| Sociétés | Poste | Fin |
|---|---|---|
| IRAY GROUP | Directeur/Membre du Conseil | 01/11/2023 |
| SHANGHAI RIGHTONGENE BIOTECHNOLOGY CO., LTD. | Directeur/Membre du Conseil | 29/11/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
iRay Technology Co., Ltd.
iRay Technology Co., Ltd. Medical SpecialtiesHealth Technology Manufactures and supplies X-ray flat panel digital detectors | Health Technology |
Shanghai Rightongene Biotechnology Co., Ltd.
Shanghai Rightongene Biotechnology Co., Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Jiangsu Subo Biomedical Holding Co. Ltd.
Jiangsu Subo Biomedical Holding Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Provides forensic and third-party medical testing services | Commercial Services |
















